Glypican-3 targeting compositions and uses thereof
TW202637574APending Publication Date: 2026-09-16PEPTIDREAM INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114148455
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-11
- Filing Date
- 2025-12-10
- Publication Date
- 2026-09-16
Smart Images

Figure 00000653_0000 
Figure 00000655_0000 
Figure 00000657_0000
Abstract
Provided herein are GPC-3 binding peptides and non-radionuclide conjugates thereof, and compositions comprising the same. The GPC-3 targeting peptides and non-radionuclide conjugates thereof have avidity to GPC3. The GPC-3 targeting peptides described herein can optionally further comprise a linker connecting the GPC-3 targeting peptide to a non-radionuclide moiety. The non-radionuclide conjugates described herein comprises the GPC-3 targeting peptide linked to a non-radionuclide moiety, either directly or through a linker. Further provided herein are methods of diagnosing and / or treating a disease or condition characterized by GPC-3 expression (e.g., overexpression), such as various cancers, by administering the described peptides and non-radionuclide conjugates thereof, or compositions thereof.
Need to check novelty before this filing date? Find Prior Art
